Opioid users showed blunted endocannabinoid stress response compared to healthy controls

A significant GROUP x TIME interaction was found for 2-AG. Healthy controls showed increased 2-AG plasma levels after social exclusion stress, while non-medical opioid users showed a blunted stress response. The groups robustly differed at all time points after stress. Higher 2-AG levels were associated with greater feelings of social inclusion. No significant interactions were found for anandamide, other NAEs, or arachidonic acid.

Individuals with chronic non-medical prescription opioid use (n=21) and matched opioid-naive controls (n=29) underwent social exclusion using the Cyberball task. Plasma was collected before and at 10, 20, 30, and 60 minutes after stress. 2-AG, anandamide, related N-acylethanolamines, and arachidonic acid were measured.

The endocannabinoid system is increasingly recognized as a critical stress buffer. If opioid use disrupts this buffering capacity, specifically the 2-AG response, it could explain why stress is such a powerful trigger for opioid relapse and why opioid users are vulnerable to emotional dysregulation.

This finding links the opioid and endocannabinoid systems in a clinically meaningful way. If 2-AG dysfunction contributes to stress vulnerability in opioid use disorder, pharmacological approaches that enhance 2-AG signaling (such as MAGL inhibitors) could represent a novel treatment strategy, potentially more targeted than broad cannabinoid receptor agonists.

Small sample sizes (21 vs 29) limit generalizability and statistical power. Cross-sectional comparison cannot determine whether the blunted response preceded or resulted from opioid use. Social exclusion (Cyberball) may not represent the types of stress that trigger real-world relapse. Plasma endocannabinoids may not perfectly reflect brain levels.